CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 2, 2001, Pages 105-115

  Nicholson, Janet K A ^a   Browning, Sandra W ^a   Hengel, Richard L ^a,b   Lew, Edward ^a   Gallagher, Laura E ^c   Rimland, David ^b,c   McDougal, J Steven ^a,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

CCR5; Chemokine receptor; CXCR4; HIV 1; Immune activation; T cells

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; MONOCLONAL ANTIBODY;

ARTICLE; CELL LEVEL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 0035363624     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200106010-00002     Document Type: Article

References (64)

1. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein coupled receptor
2. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
3. + cells is mediated by the chemokine receptor CC-CKR-5
4. Identification of a major coreceptor for primary isolates of HIV-1
5. Coreceptors: Implications for HIV pathogenesis and therapy
6. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression
7. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
8. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5
9. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
10. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro
11. Maintenance of chemokine receptor expression on peripheral and central lymphocytes in human immunodeficiency virus-1 infection
12. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
13. Detection and delineation of CXCR-4 (Fusin) as an entry and fusion cofactor for T cell-tropic HIV-1 by three different monoclonal antibodies
14. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/Fusin on various leukocyte subsets: Rapid internalization and recycling upon activation
15. CXCR4 expression during lymphopoiesis: Implications for human immunodeficiency virus type 1 infection of the thymus
16. CCR5 is characteristic of Th1 lymphocytes
17. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
18. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
19. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
20. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
21. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression
22. + T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation
23. CCR5 and CXCR4 chemokine receptor expression and β-chemokine production during early T cell repopulation induced by highly active antiretroviral therapy
24. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection
25. + Th1 phenotype
26. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy
27. Altered representation of naive and memory CD8 T cell subsets in HIV-infected children
28. CD8 naive T cell counts decrease progressively in HIV-infected adults
29. + lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
30. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: Changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens
31. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
32. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
33. HIV coreceptor down-regulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of H1V replicaton
34. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains
35. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
36. + T cells
37. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines
38. Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy
39. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-α and MIP-1β
40. +, T cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro
41. Spontaneous and antigen-induced production of HIV-inhibitory β-chemokines are associated with AIDS-free status
42. Correlation between circulating cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1 -infected individuals
43. Kinetics of beta-chemokine levels during anti-HIV therapy
44. Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection
45. Persistent alterations in T-cell repertoire and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy
46. + "naive" T-cells following triple-drug therapy for HIV-1 infection
47. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease
48. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
49. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
50. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans
51. 1997 Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)
52. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
53. + T lymphocytes during HIV-1 infection
54. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation
55. + cell levels
56. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
57. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage
58. Lymphocyte homing and homeostasis
59. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
60. Chemokines and cell migration in secondary lymphoid organs
61. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28
62. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro
63. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: Implications for transmission and pathogenesis
64. + T cell decline